Hodgkin lymphoma (HL) is a unique hematopoietic neoplasm characterized by cancerous
Reed‐Sternberg cells in an inflammatory background. Patients are commonly diagnosed …

The crude incidence of Hodgkin lymphoma (HL) in the European Union is 2.3, the mortality
0.4 cases/100000/year. Young adults aged 20–40 years are most often affected. Slightly …

The crude incidence of Hodgkin's lymphoma (HL) in the European Union is 2.3 and the
mortality is 0.4 cases/100 000/year. Young adults aged 20–40 years are most often affected; …

Management of Hodgkin's lymphoma continues to develop. Outcomes for patients with
favourable-risk, early-stage disease are excellent, and serial reductions in intensity of …

Histologic transformation (HT) to an aggressive lymphoma is a well-described event in the
natural history and clinical course of patients with so-called indolent lymphomas. This …

Early-Stage Hodgkin's Lymphoma | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Additional positron emission tomography (PET) scan may be considered according to the
revised response criteria [1]. Staging laparotomy is not recommended [II, A]. Full blood cell …

Purpose Universal expression of CD20 by malignant cells in nodular lymphocyte–
predominant Hodgkin lymphoma (NLPHL) led us to evaluate rituximab (R) as a therapeutic …

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity
with distinct pathologic and clinical characteristics. Unlike the malignant cells in classical …

Purpose The optimal treatment of stage IA nodular lymphocyte-predominant Hodgkin
lymphoma (NLPHL) is not well defined. Thus, we performed an analysis using the database …